NCT05652439View on ClinicalTrials.gov

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

RecruitingOBSERVATIONAL
Enrollment

25,000

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

Observational retrospective data collection

Observational retrospective data collection of the incidence of adverse cardiovascular and cerebrovascular outcomes

Trial Locations (1)

Unknown

RECRUITING

Clinical Practice Research Datalink (CPRD), London

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY